Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Minority Interest: 2010-2014

Historic Minority Interest for Ligand Pharmaceuticals (LGND) over the last 3 years, with Dec 2014 value amounting to -$1.9 million.

  • Ligand Pharmaceuticals' Minority Interest was N/A to -$2.8 million in Q1 2015 from the same period last year, while for Mar 2015 it was -$2.8 million, marking a year-over-year change of. This contributed to the annual value of -$1.9 million for FY2014, which is N/A change from last year.
  • Ligand Pharmaceuticals' Minority Interest amounted to -$1.9 million in FY2014, which was down 122.89% from $8.3 million recorded in FY2011.
  • In the past 5 years, Ligand Pharmaceuticals' Minority Interest ranged from a high of $8.3 million in FY2010 and a low of -$1.9 million during FY2014.
  • Its 1-year average for Minority Interest is -$1.9 million, with a median of -$1.9 million in 2014.